当前位置: 易推广 > 生物试剂/抗体/细胞 > 生化试剂 > 其他 > MedChemExpress > 产品展示 > MCE信号通路 > 蛋白偶联受体/G 蛋白 > NLX-204
NLX-204
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:8年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:91196
参观次数:10568180
联系我们
MedChemExpress
电话:021-58955995
联系人:客服部 (请说明是在易推广看到的!谢谢)
手机:13611715263
邮编:201203
邮箱:sales@medchemexpress.cn
地址:上海上海
详细内容
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
NLX-204
CAS No. : 2170405-10-2
MCE 站:NLX-204
产品活性:NLX-204 是一种具有口服活性、有效、高亲和力和选择性的 5-HT1A 受体偏向激动剂 (pKi=10.19)。NLX-204 对 α1 和 D2 受体的亲和力高于对其他脱靶受体的亲和力。NLX-204 可用于抗抑郁的研究。
研究领域:GPCR/G Protein | Neuronal Signaling
作用靶点:5-HT Receptor
In Vitro: NLX-204 (10 μM) shows substantial binding inhibition (higher than 50%) for adrenergic α1A and α2A and dopaminergic D2S receptors. NLX-204 (1 μM) exhibits much lower binding inhibition at D2 and α2A receptors but maintains a relatively high value for the α1Areceptor. NLX-204 (0.1~10 μM) has a low propensity for hERG channel blockade and suggests that the investigated series has a low risk with respect to hERG-related cardiac safety. NLX-204 also exhibits high microsomal stability. NLX-204 displays no P-gp inhibition (6.5% of inhibition at 10 μM) as well as negligible inhibition of CYP3A4 and CYP2D6 (23.2 and 15.9% at 10 μM, respectively). NLX-204 does not elicit flat body posture (FBP), a common side effect of the 5-HT1A receptor stimulation, suggesting that its preference for activation of 5-HT1A receptor-mediated ERK1/2 phosphorylation in vitro translates to preferential antidepressant effects rather than induction of ''behavioral syndrome''.
In Vivo: NLX-204 (2.5 mg/kg; p.o.) is rapidly absorbed from the gastrointestinal tract (Tmax = 15 min), reaches relatively high serum concentrations and shows higher concentration than those in serum for all doses.
NLX-204 (0.04~2.5 mg/kg; p.o.) shows that statistically significant elevation of pERK1/2 is observed at the two highest doses (2.5 and 0.63 mg/kg), but a tendency to increase pERK1/2 levels is also seen at lower doses.
NLX-204 robustly and significantly increases rat PFC ERK1/2 phosphorylation in a time dependent manner.
相关产品:Harmine | Puerarin | SCH-23390 hydrochloride | GTS-21 dihydrochloride | Dihydroergotamine mesylate | Thioridazine hydrochloride | Risperidone | WAY-100635 Maleate | SB-269970 hydrochloride | Aripiprazole | Ketanserin | Amitriptyline hydrochloride | Pimavanserin | Buspirone hydrochloride | Trazodone hydrochloride | Cisapride | Brexpiprazole | Lurasidone | Methiothepin mesylate | Lumateperone tosylate | Pindolol | Perphenazine | Quetiapine | Sertindole | 8-OH-DPAT | SB-224289 hydrochloride | Volinanserin | Levomepromazine | Paliperidone
品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物,我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物;
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果;
• 专业团队跟踪*新的制药及生命科学研究进展,为您提供全球*新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。
热门标签:nlx204